妊娠中のハイペレメシス:合併症 と 治療
Angeliki Gerede1, Sofoklis Stavros2, Efthalia Moustakli3
1Department of Obstetrics and Gynecology, Democritus University of Thrace, 69100 Alexandroupolis Campus, Greece.
Medical sciences (Basel, Switzerland)
|August 22, 2025
まとめ
妊娠中の重度の吐き気と嘔吐の形態であるHGは,母親に重大な合併症をもたらします. 現在の治療法はドキシラミン・ピリドキシンやその他の治療法ですが,管理を改善するための研究が進行中です.
科学分野:
- 産婦人科
- 妊婦と胎児の医療
- 薬理学について
背景:
- 妊娠中の吐き気と嘔吐 (NVP) の最も重篤な形態で,妊娠の0. 3- 3%に影響します.
- HGは妊娠早期の入院の主な原因で,母親の著しい罹病率と胎児への潜在的な悪影響に関連しています.
- HGの病理生理学は完全に理解されていないため,最適な管理方法については議論が続いている.
研究 の 目的:
- HGに関連する合併症に関する現在の証拠をレビューする.
- HGの様々な治療方法に関する情報を統合する.
- 総合的かつ個別化された管理戦略の必要性を強調する.
主な方法:
- 既存の文献の記述的なレビュー
- 2024年10月までのPubMed,Scopus,Medlineで実施された文献検索.
- 観察研究,コホート研究,記述研究,症例報告を含む.
主要な成果:
- HGの合併症には脱水,電解質の不均衡,ヴェルニッケ脳症,心律不整,血栓塞栓症,胎児の成長制限,早産が含まれます.
- ドキシラミン・ピリドキシン (FDA 承認),オンドンセトロン,メトクロプラミド,およびコルチコステロイドのような薬理学的治療法は,様々な有効性と安全性を示しています.
- アキュプレッシャー,食事の変化,心理療法,催眠術などの非薬学的介入は,支持する証拠が限られている.
結論:
- HGには包括的で個別化された管理計画が必要です.
- ドキシラミン・ピリドキシンが主療法であり,他の薬剤と補助的な措置が潜在的に有益である.
- HGメカニズムを理解し,治療の有効性を高め,医療と心理的ケアを統合する証拠に基づいたガイドラインを開発するには,さらなる研究が不可欠です.
関連する概念動画
Esophageal Varices-II: Clinical Features and Management
139
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
139
Mitral Valve Prolapse III: Nursing Management
36
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
36
Gastritis III: Clinical Manifestations and Management
474
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
474
Acute Pancreatitis II: Clinical Manifestations and Management
176
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
176
Hemodialysis II: Procedure and Complications
129
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
129
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
321
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
321


